Your browser doesn't support javascript.
loading
Schimke immuno-osseous dysplasia. A case report in Colombia.
Orozco, Rafael Adrián Pacheco; Padilla-Guzmán, Alejandro; Forero-Delgadillo, Jessica María; Jiménez, Vanessa Amparo Ochoa; Pachajoa, Harry; Parra, Nancy Janeth Vargas; Restrepo, Jaime M.
Afiliación
  • Orozco RAP; Servicio de genética, Fundación Valle del Lili, Cali, Colombia.
  • Padilla-Guzmán A; Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia.
  • Forero-Delgadillo JM; Servicio de nefrología pediátrica, Departamento de salud maternoinfantil, Fundación Valle del Lili, Cali, Colombia.
  • Jiménez VAO; Facultad de ciencias de la salud, Universidad Icesi, Cali, Colombia.
  • Pachajoa H; Servicio de nefrología pediátrica, Departamento de salud maternoinfantil, Fundación Valle del Lili, Cali, Colombia.
  • Parra NJV; Facultad de ciencias de la salud, Universidad Icesi, Cali, Colombia.
  • Restrepo JM; Servicio de genética, Fundación Valle del Lili, Cali, Colombia.
Mol Genet Metab Rep ; 37: 100995, 2023 Dec.
Article en En | MEDLINE | ID: mdl-37662493
Background: Schimke immune-osseous dysplasia (SIOD) is an ultra-rare multisystemic, monogenic, and autosomal recessive inherited disease caused by biallelic mutations in the SMARCAL1 gene. Approximately 100 cases have been reported worldwide. The disease is characterized by skeletal, renal, and immunological abnormalities. Case description: This is a 6-year-old female patient who debuted with nephrotic syndrome at five years of age, with a switch to corticosteroid resistance and poor response to immunosuppressive treatment received. The patient was admitted and referred to our institution due to convulsive status. During her hospitalization, thrombosis was found in the left renal vein, and a renal biopsy report of Collapsing Focal and Segmental Glomerulosclerosis (FSGS) was obtained. The patient had multiple infections during hospitalization, with T lymphocyte lymphopenia and severe IgG hypogammaglobulinemia. Additionally, given dysmorphic facies, delayed weight-height development, and spondyloepiphyseal dysplasia, exome sequencing was performed, finding an homozygous pathogenic variant c.1933C > T p.Arg645Cys in SMARCAL1, compatible with the diagnosis of SIOD. Discussion: We present the case of a patient that exhibited a severe phenotype of the disease, with skeletal, renal, severe combined immunological compromise and cerebrovascular involvement during follow-up, and the available proposed mechanisms of the disease focused on the clinical manifestations of this patient. It is the first case of SIOD reported in Colombia and the first comprehensive characterization reported in the literature of a patient with homozygosity of the known variant c.1933C > T p.Arg645Cys. Conclusion: A severe phenotype of the disease with cerebrovascular involvement by homozygosity of the known variant c.1933C > T p.Arg645Cys in the SMARCAL1 gene can be expected.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE País/Región como asunto: America do sul / Colombia Idioma: En Revista: Mol Genet Metab Rep Año: 2023 Tipo del documento: Article País de afiliación: Colombia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE País/Región como asunto: America do sul / Colombia Idioma: En Revista: Mol Genet Metab Rep Año: 2023 Tipo del documento: Article País de afiliación: Colombia Pais de publicación: Estados Unidos